INTRODUCTION
TOPNet (Targeting oxidative phosphorylation for the rational development of sterilizing drug combination for drug-resistant tuberculosis Network) is focused on creating new improved treatments for Tuberculosis (TB). The network is funded by the National Research Foundation (NRF) Competitive Research Programme (CRP), Singapore since November 2017. TOPNet is a consortium of experts from the Nanyang Technological University Singapore (NTU), National University Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR), Singapore.
The 1st Annual Symposium From crisis to cures: New approaches to TB Drug discovery of TOPNet brings together renowned scientists, leaders and advisers of world-wide leading institutions in TB.